Histamine and IL-2 before surgery for pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether a combination of two drugs, histamine and IL-2, given before surgery can help treat pancreatic cancer. It may help the immune system fight the cancer and improve outcomes after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with primary pancreatic cancer (confirmed by imaging or biopsy).
- Your surgeon has evaluated you and considers you fit for pancreatic surgery.
- You do not have serious heart problems, uncontrolled seizures, or other significant medical conditions that would make the treatment unsafe.
- If you are a woman who can become pregnant, you must agree to use effective birth control during the study and for 5 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two drugs, tislelizumab and SX-682, given before surgery for people with pancreatic cancer that can be removed. The goal is to see if this combination shrinks tumors and improves outcomes.
This trial tests if giving a combination of four drugs before and after surgery can help treat pancreatic cancer. The drugs include HRS-4642, gemcitabine, nab-paclitaxel, and adebrelimab. It may help shrink the tumor before surgery and lower the chance of cancer coming back afterward.
This trial tests a combination of an immunotherapy drug (adebrelimab) with chemotherapy before surgery for pancreatic cancer. The goal is to see if this approach can shrink the tumor and improve outcomes for patients whose cancer can be surgically removed.
This trial tests a combination of chemotherapy drugs given before and after surgery for pancreatic cancer that is considered high-risk but removable. The goal is to see if this approach can improve outcomes for patients with this type of cancer.
This trial tests whether giving a steroid called hydrocortisone before and after surgery to remove part of the pancreas can help patients recover better. It aims to reduce complications and improve outcomes.
This trial tests a new drug (HRS-4642) given with chemotherapy, with or without immunotherapy, before surgery for pancreatic cancer. The goal is to see if this combination can shrink tumors and improve outcomes.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.